Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    20818854 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Interventions: Drug: busulfan;   Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Procedure: hematopoietic bone marrow transplantation

Study has passed its completion date and status has not been verified in more than two years.